Add time:08/16/2019 Source:sciencedirect.com
Childhood maltreatment (CM) is associated with chronic low-grade inflammation and an increased risk for the development of adverse mental and physical health outcomes in CM-affected adults. Differences in cortisol signaling were described to contribute to this pro-inflammatory phenotype. We investigated in a study cohort of 13 postpartum women with and 12 postpartum women without CM whether treatment of peripheral blood mononuclear cells (PBMC) with cortisol, the anti-glucocorticoid hormone dehydroepiandrosterone (DHEA), or co-treatment with both differentially affected pro-inflammatory cytokine release ex vivo. The childhood trauma questionnaire was used to retrospectively assess CM and the severity of CM experiences (maltreatment load). PBMC of maltreated women (CM+) showed in all conditions an increase in pro-inflammatory cytokine secretion compared to PBMC of the control group (CM-), which was correlated with the maltreatment load. Ex vivo stimulation analyses provided preliminary evidence for a differential responsivity of PBMC in CM+ and CM- women to cortisol regarding TNF-α secretion, but no difference in the responsivity to DHEA treatment. The results of the co-treatment with cortisol and DHEA support the hypothesis that cortisol and DHEA interact in the modulation of inflammatory processes.
We also recommend Trading Suppliers and Manufacturers of cortisol 21-sulfate (cas 1253-43-6). Pls Click Website Link as below: cas 1253-43-6 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View